| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |